These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38554066)

  • 1. Abnormal Colorectal Cancer Test Follow-Up: A Quality Improvement Initiative at a Federally Qualified Health Center.
    Shareef F; Bharti B; Garcia-Bigley F; Hernandez M; Nodora J; Liu J; Ramers C; Nery JD; Marquez J; Moyano K; Rojas S; Arredondo E; Gupta S
    J Prim Care Community Health; 2024; 15():21501319241242571. PubMed ID: 38554066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center.
    Escaron AL; Garcia J; Petrik AF; Ruiz E; Nyongesa DB; Thompson JH; Coronado GD
    J Prim Care Community Health; 2022; 13():21501319221138423. PubMed ID: 36448466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.
    Bharti B; May FFP; Nodora J; Martínez ME; Moyano K; Davis SL; Ramers CB; Garcia-Bigley F; O'Connell S; Ronan K; Barajas M; Gordon S; Diaz G; Ceja E; Powers M; Arredondo EM; Gupta S
    Cancer; 2019 Dec; 125(23):4203-4209. PubMed ID: 31479529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
    Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
    Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up colonoscopy after an abnormal stool-based colorectal cancer screening result: analysis of steps in the colonoscopy completion process.
    Coronado GD; Kihn-Stang A; Slaughter MT; Petrik AF; Thompson JH; Rivelli JS; Jimenez R; Gibbs J; Yadav N; Mummadi RR
    BMC Gastroenterol; 2021 Sep; 21(1):356. PubMed ID: 34583638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Fecal Immunochemical Test Return Rates: A Colorectal Cancer Screening Quality Improvement Project in a Multisite Federally Qualified Health Center.
    Zoellner JM; Porter KJ; Thatcher E; Allanson D; Brauns M
    Health Promot Pract; 2023 Jul; 24(4):740-754. PubMed ID: 35382617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient randomized trial of a targeted navigation program to improve rates of follow-up colonoscopy in community health centers.
    Coronado GD; Johnson ES; Leo MC; Schneider JL; Smith D; Mummadi R; Petrik AF; Thompson JH; Jimenez R
    Contemp Clin Trials; 2020 Feb; 89():105920. PubMed ID: 31881390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hub-and-Spoke centralized intervention to optimize colorectal cancer screening and follow-up: A pragmatic, cluster-randomized controlled trial protocol.
    Castañeda SF; Gupta S; Nodora JN; Largaespada V; Roesch SC; Rabin BA; Covin J; Ortwine K; Preciado-Hidalgo Y; Howard N; Halpern MT; Martinez ME
    Contemp Clin Trials; 2023 Nov; 134():107353. PubMed ID: 37802222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions on Barriers and Facilitators to Colonoscopy Completion After Abnormal Fecal Immunochemical Test Results in a Safety Net System.
    Issaka RB; Bell-Brown A; Snyder C; Atkins DL; Chew L; Weiner BJ; Strate L; Inadomi JM; Ramsey SD
    JAMA Netw Open; 2021 Aug; 4(8):e2120159. PubMed ID: 34374771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multi-Level Fit-Based Quality Improvement Initiative to Improve Colorectal Cancer Screening in a Managed Care Population.
    Yu C; Skootsky S; Grossman M; Garner OB; Betlachin A; Esrailian E; Hommes DW; May FP
    Clin Transl Gastroenterol; 2018 Sep; 9(8):177. PubMed ID: 30177700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized Workflows Improve Colonoscopy Follow-Up After Abnormal Fecal Immunochemical Tests in a Safety-Net System.
    Issaka RB; Rachocki C; Huynh MP; Chen E; Somsouk M
    Dig Dis Sci; 2021 Mar; 66(3):768-774. PubMed ID: 32236885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics.
    Petrik AF; Keast E; Johnson ES; Smith DH; Coronado GD
    BMC Health Serv Res; 2020 Nov; 20(1):1028. PubMed ID: 33172444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
    Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
    J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.
    Gupta S; Coronado GD; Argenbright K; Brenner AT; Castañeda SF; Dominitz JA; Green B; Issaka RB; Levin TR; Reuland DS; Richardson LC; Robertson DJ; Singal AG; Pignone M
    CA Cancer J Clin; 2020 Jul; 70(4):283-298. PubMed ID: 32583884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equitable Implementation of Mailed Stool Test-Based Colorectal Cancer Screening and Patient Navigation in a Safety Net Health System.
    Scott RE; Chang P; Kluz N; Baykal-Caglar E; Agrawal D; Pignone M
    J Gen Intern Med; 2023 May; 38(7):1631-1637. PubMed ID: 36456842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
    Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
    JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve three-year adherence to colorectal cancer screening among patients cared for in rural community health centers.
    Davis TC; Morris JD; Reed EH; Curtis LM; Wolf MS; Davis AB; Arnold CL
    Contemp Clin Trials; 2022 Feb; 113():106654. PubMed ID: 34906745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial.
    Coronado GD; Petrik AF; Vollmer WM; Taplin SH; Keast EM; Fields S; Green BB
    JAMA Intern Med; 2018 Sep; 178(9):1174-1181. PubMed ID: 30083752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systems-based Strategies Improve Positive Screening Fecal Immunochemical Testing Follow-up and Reduce Time to Diagnostic Colonoscopy.
    Sadowski BW; Bush AM; Humes R; Cullen P; Hopkins I; Chen YJ; McCarthy J; Tritsch AM; Laczek JT
    Mil Med; 2022 May; 187(5-6):e554-e557. PubMed ID: 33410872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.